Eric Linsley
Partner
A. M. Pappas & Associates

Eric Linsley is an experienced operating executive and venture capital investor who joined A. M. Pappas & Associates (AMP&A) in early 2000. He currently serves on the Board of Directors of Emerald BioAgriculture, Panacos Pharmaceuticals, and Signase. Prior to joining AMP&A he served as Chief Financial Officer of TriPath Imaging, Inc. (Nasdaq: TPTH), a medical device company. Mr. Linsley played a key role in the three-way merger between AutoCyte, NeoPath and Neuromedical Systems that created TriPath. Prior to the merger, he served as Chief Financial Officer and Vice President of Operations at AutoCyte. From 1991 to 1997, Mr. Linsley worked as an investment professional with Ampersand Ventures. He previously served as a management consultant with Bain & Co. and McKinsey & Co.

Mr. Linsley received a B.A. in Economics at Trinity College, an M.S. in Accounting at New York University and an M.B.A. at the Wharton School of the University of Pennsylvania.